|
FY2025
3 months to Dec 31, 2025
|
|
|---|---|
| Cash Flows from Operating Activities: | |
| Net Income Loss | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Changes in operating assets and liabilities: | |
| Accrued expenses | |
| Net cash used in operating activities | |
| Cash Flows from Financing Activities: | |
| Proceeds from issuance of Class B ordinary shares | |
| Proceeds from promissory note – related party | |
| Payment of deferred offering costs | |
| Net cash provided by financing activities | |
| Net Change in Cash | |
| Cash – Beginning of period | |
| Cash – End of period | |
| Non-cash investing and financing activities: | |
| Deferred offering costs included in accrued offering costs |
Loading...
